COVID-19 pandemic, as experienced in the surgical service of a district hospital in Spain

Table 1 Impacts produced on elective procedures in different scenarios[12]

	1	2	3	4	5
Effectiveness of conservativetreatment	None/not available	< 40% of that provided by surgery	40%-60% of that provided by surgery	60%-95% of that provided by surgery	Fully equivalent to that provided by surgery
Impact of a 2-wk delay on disease prognosis	Very severe worsening	Significant worsening	Moderate worsening	Slight worsening	No worsening
Impact of a 6-wk delay on disease prognosis	Very severe worsening	Significant worsening	Moderate worsening	Slight worsening	No worsening
Surgical time (min)	< 30	30-60	60-120	120-180	> 180
Average hospital stay	Minor surgery/major ambulatory surgery	< 24 h	24-48 h	3 d	> 4 d
Likelihood of need for ICU (%)	Unlikely	< 5	5-10	10-25	> 25
Blood required (cc)	< 100	100-250	250-500	500-750	> 750
Members of the surgical team	1	2	3	4	> 4
Location of surgery	None of the following	Upper and lower abdomen, by laparoscopy	Lower abdomen, open surgery	Upper abdomen, open surgery	Head and neck, thorax, gastro-oesophageal complex
Age	< 20	20-40	40-50	50-65	> 65
Chronic lung pathology (COPD, asthma, cystic fibrosis)	No			Treatment on demand	Usual treatment
Obstructive sleep apnea syndrome	No			No treatment	Continuous positive airway pressure
Cardiovascular disease	No		1 drug	2 drugs	3 drugs
BMI (kg/m2)	< 25			25-30	> 30
Diabetes mellitustype 2	No		No medication	Oral antidiabetic	+ Insulin
Immunosuppression	No			Moderate	Severe
Flu syndrome	No				Yes
Contact with COVID-19 in the last 15 d	No		Unknown		Yes

BMI: Body mass index; COPD: Chronic obstructive pulmonary disease; COVID-19: Coronavirus disease 2019; ICU: Intensive care unit.